Fuat SU ERNİS, Buğra Doğukan TÖRER, Ramazan KOCAKAYA, Volkan TUĞCU, Ali İhsan TAŞÇI

Benign prostat hiperplazisi tedavisinde TUR-P (Monopolar/Bipolar), greenlight- fotoselektif Prostat Vaporizasyon (PVP) ve Transvezikal Prostatektomi (TVP) uygulamalarının cinsel fonksiyonlar üzerine olan etkileri

Amaç: IIEF-15 sorgu formuyla BPH tedavisinde kullanılan cerrahi yöntemlerin cinsel fonksiyonlara olan etkileri incelenmiştir. Gereç ve Yöntemler: Çalışma Ocak 2008- Haziran 2011 tarihleri arasında, BPH tanısı alan, 50-75 yaş aralığında, cinsel yönden aktif 80 erkek hasta çalışmaya dahil edildi. Hastalar, 4 eşit gruba ayrıldı. Prostat volümü 100 cc’nin altında olan üç gruba sırasıyla TUR-P monopolar, TUR-P bipolar, KTP (green light) lazer vaporizasyonu, prostat volümü 100 cc’nin üzerinde olan dördüncü gruba transvezikal prostatektomi (TVP) yapıldı. Hastaların preoperatif ve postoperatif IPSS, yaşam kalitesi (QoL) skoru ve IIEF-15 değerleri karşılaştırıldı. Bulgular: Çalışmamıza katılan 80 hastanın yaş ortalaması 63.4 ± 6.4, prostat hacimleri 81,17 ± 30,5 cc, IPSS semptom skoru 26±4,2 , yaşam kalitesi (QoL) skoru 5 ± 0,9 olduğu görüldü. Postoperatif dönemde IPSS skorunun 7,14±3,26’ya ve QoL’ın 1,37±0,59’a gerilediği izlendi (p

The effects of TUR-P (Monopolar/Bipolar), greenlight-photoselective Vaporization of the Prostate (PVP) and Transvesical Prostatectomy (TVP) in the treatment of benign prostatic hyperplasia on Sexual function

Objective: The effects of surgical techniques which used in BPH treatment by IIEF-15 query form on sexual function was investigated. Materials and Methods: The study was January 2008 - June 2011 between BPH diagnosed between the ages of 50-75, sexually active, 80 male patients were included in the study. Patients were divided into 4 equal groups. Prostate volume of the three groups, respectively under 100 cc TUR-P monopolar, bipolar TURP, KTP (gre- en light) laser vaporization of the prostate volu- me 100 cc’s the fourth group on the transvesical prostatectomy (TVP) was performed. Preopera- tive and postoperative IPSS, quality of life (QoL) score and IIEF-15 values are compared.  Results: The mean age of the 80 patients par- ticipating in our study, 63.4 ± 6.4, 81.17 ± 30.5 cc prostate volume, IPSS symptom score was 26 ± 4.2, quality of life (QoL) scores were found to be 5 ± 0.9. IPSS score in the postoperative period, 7.14 ± 3.26 to 1.37 ± 0.59 and QoL is ‘showed a decreased (p <0.01). All groups were considered, erectile function, intercourse satisfaction, libido, overall satisfaction levels of preoperative 21.39 ± 4.26 to 20.53 ± 5.53, respectively, to postoperati- ve, 9.96 ± 2.57 to 9.36 ± 3 , 44, 7.00 ± 1.29 to 7.11 ± 1.55, 7.19 ± 1.30 to 6.73 ± 2.19 and that they were not affected operations. Orgasmic function in terms of the values  all patients postoperati- of vely compared with preoperative values, a statistically significant decrease (p <0.01). Conclusion: According to IIEF-15 except for the evaluation orgasmic function, sexual function parameters monopolar TUR-P / bipolar, Greenlight laser vaporization and affected than transvesical prostatec- tomy.

PDF

___

1. Akkus E, Kadioglu A, Esen A, et al. Prevalence and correlates of erectile dysfunction in Turkey: a populationbased study. Eur Urol 2002;41:298-304.
2. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-44.
3. Braun M, Wassmer G, Klotz T, et al. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res 2000;12:305-11.
4. Braun MH, Sommer F, Haupt G, et al. Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical ‘Aging Male’ symptoms? Results of the ‘Cologne Male Survey’. Eur Urol 2003;44:588-94.
5. Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003;44: 637-49.
6. (83)Andrea Tubaro, Simon Carter, Ahmad Hind, et al. A prospective study of the safety and efficacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia. J Urol 2001;166:172-6.
7. Naspro R, Suardi N, Salonia A, et al. Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70g: 24-month follow-up. Eur Urol. 2006 ;50:563-8.
8. Lindner A, Golomb J, Korczak D, et al. Effects of prostatectomy on sexual function. Urology 1991; 38:26–8.
9. Soderdahl D, Knight R, Hansberry K. Erectile dysfunction following transurethral resection of the prostate. J Urol 1996;156:1354–6.
10. Tscholl R, Largo M, Poppinghaus H, et al. Incidence of erectile impotence secondary to transurethral resection of benign prostatic hyperplasia, assessed by preoperative and postoperative Snap Gauge tests. J Urol 1995;153:1491–3.
11. Madersbacher S, Marberger M, Donovan JL, et al. Is transurethral resection of the prostate still justified? Br J Urol 1999;83:227-37.
12. Rassweiler J, Teber D, Kuntz R, et al. Complications of transurethral resection of the prostate (TURP). Incidence, management, and prevention. Eur Urol 2006 ;50:969-79.
13. Seong Beom Choi, Chen Zhao, Jong Kwan Park . The Effect of Transurethral Resection of the Prostate on Erectile Function in Patients with Benign Prostatic Hyperplasia. Korean J Urol 2010;51:557-560.
14. Kaya C, Ilktaç A, Gokmen E, et al. The long-term results of transurethral vaporization of the prostate using plasmakinetic energy. BJU Int 2007;99:845-848.
15. Akman T, Binbay M, Tekinarslan E,et al. Effects of bipolar and monopolar transurethral resection of the prostate on urinary and erectile function: a prospective randomized comparative study. BJU Int. 2012 Jun 6. doi: 10.1111/j.1464- 410X.2012.11266.x. (Epub ahead of print)
16. De la Rosette J, Alivizatos G, Madersbacher S, et al. EAU guidelines on benign prostatic hyperplasia (BPH). Eur Urol 2001;40: 256-63.
17. Alexis E, Terrence R, Malloy BS, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States Multicenter Prospective Trial. J Urol 2004; 172: 1404-08.
18. Chandrasekera SK, Barber NJ, Walsh K, et al. High power 80W Nd:YAG/KTP laser vaporization of the prostate with 1 year follow up. Lasers Surg Med 2005;69: 1404-8.
19. Reich O, Bachmann A, Schneede P, et al. Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol 2004;171:2502-4.
20. Kuntzman RS, Malek RS, Barrett DM, et al. Potassiumtitanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines. Urology 1996;48:575-83.
21. Malek RS, Kuntzman RS, Barrett DM. High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol. 2000;163:1730-3.
22. Malek RS. Photoselective KTP laser vaporization of obstructive BPH (PVP). In: Baba S, Ono Y, editors. Interventional management of urological diseases. Tokyo: Springer- Verlag; 2006. pp. 103-122.
23. Rocco Damiano, Riccardo Autorino. Sexual Outcome Following Photoselective Vaporization of the Prostate: Is There Enough Evidence ? Eur Urol 2010;58:214-15.
24. Paick JS, Um JM, Kim SW, et al. Influence of high-power potassiumtitanyl- phosphate photoselective vaporization of the prostate on erectile function: a short-term follow-up study. J Sex Med 2007; 4:1701–7.
25. Hamann MF, Naumann CM, Seif C, et al. Functional outcome following photoselective vaporisation of the prostate (PVP): Urodynamic findings within 12 months follow-up. Eur Urol 2008;54: 902-10.
26. Kavoussi PK, Hermans MR. Maintenance of erectile function after photoselective vaporization of the prostate for obstructive benign prostatic hyperplasia. J Sex Med 2008;5: 2669-71.